PATENT CLAIM ANALYSIS

Application Number: 15970128
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "235800"]

Abstract:
The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of an HBV capsid assembly inhibitor and an interferon for use in the treatment of hepatitis B virus infections.

Claim (Index 19):
The method according to any one of  claims 12  to  18 , wherein the interferon is a non-conjugated interferon alfa or a pegylated alfa-type interferon; particularly the interferon is Roferon A, Intron A, Pegasys or PegIntron; more particularly the interferon is Roferon A or Pegasys.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 93.0
- Lexical Diversity: 1.38889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14640397', '14946595', '14279716', '14991786', '14839376']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.825301259231374
- 35 USC 102 Novelty (BERT): 0.6055359934977315
- Combined Prediction Score: 0.8033247326580097
- Mean Citation Score: 514.621874
- Max Citation Score: 716.02423
- Similarity Product: 428.57456855411885

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test